​

The EXPRESS study is a 3-year NIHR HS&DR funded project. With collaborative effort from colleagues around the UK and input from a PPI Advisory Group, our research will use a variety of methods to evaluate the new prenatal exome sequencing (pES) service. 

You can view our key objectives here.